Apyx Medical Corporation, a manufacturer of medical devices and supplies and the innovator of Helium Plasma Technology, marketed and sold as Renuvion® and J-Plasma® in surgical markets, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the use of the Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is utilized for dermatological procedures that treat moderate to severe wrinkles and rhytides, specifically to patients with Fitzpatrick skin types I, II or III.
Apyx Medical Corporation is a technology company that strives to elevate people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion® and J-Plasma® in surgical markets. Renuvion® and J-Plasma® offer surgeons a distinctive ability to provide controlled heat to tissue to achieve their desired results. The Company also displays its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.
Read more here